• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反流时间是膀胱输尿管反流内镜治疗成功的预测指标。

Reflux Timing Is a Predictor of Successful Endoscopic Treatment of Vesicoureteral Reflux.

作者信息

Han Daniel S, Cambareri Gina, Alagiri Madhu, Chiang George

机构信息

Pediatric Urology, University of California San Diego, Rady Children's Hospital, San Diego, CA.

Pediatric Urology, University of California San Diego, Rady Children's Hospital, San Diego, CA.

出版信息

Urology. 2019 Feb;124:237-240. doi: 10.1016/j.urology.2018.09.034. Epub 2018 Oct 29.

DOI:10.1016/j.urology.2018.09.034
PMID:30385258
Abstract

OBJECTIVE

To determine whether vesicoureteral reflux (VUR) that occurs during either the filling or voiding phase on voiding cystourethrogram (VCUG) has prognostic significance on successful endoscopic treatment.

MATERIALS AND METHODS

A retrospective review was performed of 299 patients (438 ureters) with VUR who underwent endoscopic treatment with dextranomer/hyaluronic acid copolymer (Deflux) at a single institution from 2010 to 2013. Success was defined as absence of VUR on 3-month follow-up VCUG. Preoperative VCUGs were analyzed to determine whether the onset of VUR occurred during the filling or voiding phase. Predictor variables to determine success were analyzed, with a specific focus on VUR timing.

RESULTS

Success rate was 319/438 (72.8%) by ureter and 202/299 (67.6%) by patient. Reflux was seen during the filling and voiding phases in 290 and 148 ureters, respectively. Success rate was 203/290 (78%) for filling VUR and 116/148 (70%) for voiding VUR. Univariable analysis revealed voiding VUR had significantly increased odds of success (odds ratio [OR] 3.2, P = .049), while high-grade reflux (OR 0.53, P = .005) had significantly decreased odds of success. Multivariable analysis showed that voiding VUR (OR 3.2, P = .005) had significantly higher odds of success while those with high grade reflux (OR 0.42, P = .017) had significantly decreased odds of success.

CONCLUSION

The timing of VUR on preoperative VCUG appears to be an important independent predictor of successful endoscopic treatment of VUR. This has important clinical considerations when selecting VUR patients who would be best candidates for endoscopic treatment.

摘要

目的

确定排尿性膀胱尿道造影(VCUG)充盈期或排尿期出现的膀胱输尿管反流(VUR)对内镜治疗成功与否是否具有预后意义。

材料与方法

对2010年至2013年在单一机构接受葡聚糖omer/透明质酸共聚物(Deflux)内镜治疗的299例VUR患者(438条输尿管)进行回顾性研究。成功定义为3个月随访VCUG时无VUR。分析术前VCUG以确定VUR发作是发生在充盈期还是排尿期。分析确定成功的预测变量,特别关注VUR发生时间。

结果

按输尿管计算成功率为319/438(72.8%),按患者计算为202/299(67.6%)。分别在290条和148条输尿管的充盈期和排尿期观察到反流。充盈期VUR的成功率为203/290(78%),排尿期VUR的成功率为116/148(70%)。单因素分析显示,排尿期VUR成功的几率显著增加(优势比[OR]3.2,P = 0.049),而高级别反流(OR 0.53,P = 0.005)成功的几率显著降低。多因素分析表明,排尿期VUR(OR 3.2,P = 0.005)成功的几率显著更高,而高级别反流患者(OR 0.42,P = 0.017)成功的几率显著降低。

结论

术前VCUG上VUR的发生时间似乎是VUR内镜治疗成功的重要独立预测因素。在选择最适合内镜治疗的VUR患者时,这具有重要的临床意义。

相似文献

1
Reflux Timing Is a Predictor of Successful Endoscopic Treatment of Vesicoureteral Reflux.反流时间是膀胱输尿管反流内镜治疗成功的预测指标。
Urology. 2019 Feb;124:237-240. doi: 10.1016/j.urology.2018.09.034. Epub 2018 Oct 29.
2
VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapy.排尿性膀胱尿道造影(VCUG)时的膀胱输尿管反流(VUR)时机作为内镜治疗后VUR消退的预测因素。
J Pediatr Urol. 2016 Aug;12(4):255.e1-6. doi: 10.1016/j.jpurol.2016.04.002. Epub 2016 May 6.
3
Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?原发性膀胱输尿管反流双重打击后,常规排尿性膀胱尿道造影是否必要?
J Pediatr Urol. 2015 Feb;11(1):40.e1-5. doi: 10.1016/j.jpurol.2014.11.011. Epub 2015 Jan 30.
4
Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary?在初次使用葡聚糖凝胶/透明质酸共聚物(Dx/HA)成功进行内镜治疗膀胱输尿管反流(VUR)后进行常规延迟排尿膀胱尿道造影。有必要吗?
Actas Urol Esp. 2016 Dec;40(10):635-639. doi: 10.1016/j.acuro.2016.02.007. Epub 2016 May 6.
5
Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?影响膀胱输尿管反流内镜治疗成功的因素及两种基于葡聚糖omer的填充剂的比较:填充物质重要吗?
J Pediatr Urol. 2015 Apr;11(2):90.e1-5. doi: 10.1016/j.jpurol.2014.12.009. Epub 2015 Mar 2.
6
Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).聚丙烯酸-聚醇共聚物(PPC)与葡聚糖-透明质酸共聚物(Dx/HA)作为内镜治疗原发性膀胱输尿管反流(VUR)的膨胀剂的随机临床试验。
World J Urol. 2018 Oct;36(10):1651-1656. doi: 10.1007/s00345-018-2314-7. Epub 2018 May 3.
7
Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux.用于预测原发性膀胱输尿管反流患儿内镜注射成功率的其他排尿性膀胱尿道造影相关参数。
J Pediatr Urol. 2021 Feb;17(1):68.e1-68.e8. doi: 10.1016/j.jpurol.2020.11.018. Epub 2020 Nov 20.
8
Utility of an intra-operative cystogram with a simulated voiding phase after endoscopic treatment of vesicoureteral reflux.内镜治疗膀胱输尿管反流后术中膀胱造影及模拟排尿期的效用
W V Med J. 2008 Jul-Aug;104(4):22-4.
9
Outcomes of vesicoureteral reflux in children with non-neurogenic lower urinary tract dysfunction treated with dextranomer/hyaluronic acid copolymer (Deflux).用葡聚糖omer/透明质酸共聚物(Deflux)治疗非神经源性下尿路功能障碍儿童的膀胱输尿管反流结果。
J Pediatr Urol. 2014 Jun;10(3):482-7. doi: 10.1016/j.jpurol.2013.10.017. Epub 2013 Nov 12.
10
The reliability of VCUG performed within 24 hours after injection of dextranomer/hyaluronic acid in patients with vesico-ureteral reflux.注射葡聚糖/透明质酸后 24 小时内行 VCUG 的可靠性在患有膀胱输尿管反流的患者中。
Urology. 2014 Jan;83(1):191-4. doi: 10.1016/j.urology.2013.07.035. Epub 2013 Sep 13.

引用本文的文献

1
Long-Term Effectiveness of Onabotulinum Toxin-A in a Combined Total Endoscopic Management of Pediatric Vesicoureteral Reflux in Neurogenic Bladder Dysfunction.奥曲肽毒素A在神经源性膀胱功能障碍小儿膀胱输尿管反流综合内镜治疗中的长期疗效
Toxins (Basel). 2025 Jun 29;17(7):330. doi: 10.3390/toxins17070330.
2
An evaluation of ureteral diameter ratio and vesicoureteral reflux index in the treatment of primary vesicoureteral reflux.输尿管直径比和膀胱输尿管反流指数在原发性膀胱输尿管反流治疗中的评估
Asian J Urol. 2024 Jul;11(3):437-442. doi: 10.1016/j.ajur.2023.05.007. Epub 2023 Dec 9.
3
Update on imaging recommendations in paediatric uroradiology: the European Society of Paediatric Radiology workgroup session on voiding cystourethrography.
儿科泌尿放射学影像推荐的最新进展:欧洲儿科放射学会关于排尿性膀胱尿道造影术的工作组会议
Pediatr Radiol. 2024 Apr;54(4):606-619. doi: 10.1007/s00247-024-05883-y. Epub 2024 Mar 11.
4
Antireflux endoscopic injection therapy in post-pubertal patients via techniques adopted for the dilated ureteral orifice: a retrospective single-center study.经输尿管口扩张技术行抗反流内镜下注射治疗青春期后患者:回顾性单中心研究。
BMC Urol. 2021 Apr 24;21(1):70. doi: 10.1186/s12894-021-00842-3.
5
Mid-Term Safety and Efficacy of the Modified Double Hydrodistention Implantation Technique (HIT), Termed Systematic Multi-Site HIT (SMHIT), for Patients with Primary Vesicoureteral Reflux.改良双水扩张植入技术(HIT),即系统性多部位HIT(SMHIT),用于原发性膀胱输尿管反流患者的中期安全性和有效性。
Res Rep Urol. 2020 Oct 28;12:517-525. doi: 10.2147/RRU.S279240. eCollection 2020.